Roberts, Glore & Co’s Cardinal Health CAH Stock Holding History

Roberts, Glore & Co’s Portfolio CAH Stock Details CAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$280K	Hold	1,178	–	–	0.07%	196
2026 Q1	$249K	Hold	1,178	–	–	0.07%	189
2025 Q4	$242K	Buy	+1,178	New	+$222K	0.06%	194

Other funds holding CAH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Roberts, Glore & Co's CAH Position: Q2 2026 in Review

Roberts, Glore & Co held its Cardinal Health (CAH) position steady in Q2 2026 at 1,178 shares worth $280K. The position accounts for 0.07% of the portfolio, ranked #196.

Roberts, Glore & Co first reported a position in CAH in Q4 2025 and has held it in 3 quarters since. 1,498 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

Roberts, Glore & Co held 1,178 shares of Cardinal Health worth $280K as of Q2 2026.
Roberts, Glore & Co left its Cardinal Health share count unchanged in Q2 2026.
Cardinal Health made up 0.07% of Roberts, Glore & Co's portfolio in Q2 2026, its #196 holding.
Roberts, Glore & Co first reported a position in Cardinal Health in Q4 2025 and has held it in 3 quarters since.
1,498 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Roberts, Glore & Co's 13F filing for Q2 2026, filed 11 Aug 2026.